GRx+Biosims: Engineering the Future of Generic & Biosimilar Medicines
Date & Time
September 5, 2018
Add to Calendar Disabled
As numerous states wrestle with the issue of drug pricing and our nation’s opioid crisis, several have considered or enacted legislation that would affect generics and biosimilars. Ms. Trunk will provide an overview of new state law proposals as well as litigation arguments against some of these proposals, including those in Maryland, California and Nevada.
- Related Industries